Literature DB >> 18430912

Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.

John Hsu1, Vicki Fung, Mary Price, Jie Huang, Richard Brand, Rita Hui, Bruce Fireman, Joseph P Newhouse.   

Abstract

CONTEXT: Medicare Part D drug benefits include substantial cost sharing.
OBJECTIVE: To determine beneficiaries' knowledge of benefits and cost responses. DESIGN, SETTING, AND PARTICIPANTS: Telephone interviews were conducted in 2007 in a stratified random sample of community-dwelling Kaiser Permanente-Northern California Medicare Advantage beneficiaries aged 65 years or older, with a gap in coverage if they exceeded $2250 in drug costs (N = 1040; 74.9% response rate). Half were selected to have reached the gap in 2006. In the source population of Medicare Advantage Prescription Drug plan beneficiaries, 8% entered the coverage gap in 2006. Models were adjusted for individual characteristics and weighted for sampling proportions. MAIN OUTCOME MEASURES: Knowledge of cost sharing including awareness of the coverage gap, gap start and end amounts, and drug cost sharing before, during, and after the gap. Cost-related responses including cost-coping behaviors (eg, switching to lower-cost medications), reduced adherence (eg, not refilling prescriptions), and financial burden (eg, going without necessities).
RESULTS: An estimated 40% (95% confidence interval [CI], 35%-45%) of beneficiaries were aware that their drug plan in 2006 included a coverage gap; knowledge of the gap was greater among individuals who reached the gap during the year. Approximately 36% (95% CI, 32%-41%) of beneficiaries reported at least 1 of the following responses to drug costs: cost-coping behavior (26%), reduced adherence (15%), or experiencing financial burden (7%). In multivariate analyses, beneficiaries with lower household income more frequently reported cost responses (difference of 14.5 percentage points for < $40,000/y vs > or = $40,000/y [95% CI, 3.6-25.4 percentage points]). Compared with beneficiaries who were unaware of having a coverage gap, those who were aware more frequently reported any cost response (difference of 11.3 percentage points [95% CI, 0.8-21.9 percentage points]), but had fewer reports of borrowing money or going without necessities (difference of 5.5 percentage points [95% CI, 1.1-10.0 percentage points]).
CONCLUSIONS: Beneficiaries in this Medicare Advantage plan have limited knowledge of Part D cost sharing and often report behavioral responses to drug costs. Limited knowledge is associated with fewer reports of cost responses overall, but more reports of financial burden.

Entities:  

Mesh:

Year:  2008        PMID: 18430912     DOI: 10.1001/jama.299.16.1929

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  36 in total

1.  COBRA ARRA subsidies: was the carrot enticing enough?

Authors:  Ilana Graetz; Mary Reed; Vicki Fung; William H Dow; Joseph P Newhouse; John Hsu
Journal:  Health Serv Res       Date:  2012-04-19       Impact factor: 3.402

2.  Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.

Authors:  Christine E Bishop; Andrew M Ryan; Daniel M Gilden; Joanna Kubisiak; Cindy Parks Thomas
Journal:  Health Serv Res       Date:  2009-03-02       Impact factor: 3.402

3.  Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach.

Authors:  Kara Zivin; Scott Ratliff; Michele M Heisler; Kenneth M Langa; John D Piette
Journal:  Value Health       Date:  2010-01-08       Impact factor: 5.725

4.  Medicare part D enrollment in a biracial community-based population of older adults.

Authors:  Kimberly A Skarupski; Carlos F Mendes de Leon; Lisa L Barnes; Denis A Evans
Journal:  Gerontologist       Date:  2009-06-16

5.  Medicare Part D: a successful start with room for improvement.

Authors:  Dana P Goldman; Geoffrey F Joyce
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

6.  Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Authors:  Dana Gelb Safran; Michelle Kitchman Strollo; Stuart Guterman; Angela Li; William H Rogers; Patricia Neuman
Journal:  J Gen Intern Med       Date:  2009-10-31       Impact factor: 5.128

7.  Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey.

Authors:  Meng Li; Mark Bounthavong
Journal:  J Gen Intern Med       Date:  2019-07-24       Impact factor: 5.128

8.  Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.

Authors:  Vicki Fung; Carol M Mangione; Jie Huang; Norman Turk; Elaine S Quiter; Julie A Schmittdiel; John Hsu
Journal:  Health Serv Res       Date:  2009-12-30       Impact factor: 3.402

9.  The effects of the coverage gap on drug spending: a closer look at Medicare Part D.

Authors:  Yuting Zhang; Julie Marie Donohue; Joseph P Newhouse; Judith R Lave
Journal:  Health Aff (Millwood)       Date:  2009-02-03       Impact factor: 6.301

10.  Entering and exiting the Medicare part D coverage gap: role of comorbidities and demographics.

Authors:  Susan L Ettner; Neil Steers; O Kenrik Duru; Norman Turk; Elaine Quiter; Julie Schmittdiel; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2010-03-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.